TEM-C: Temperature Evaluation by MRI Thermometry During Cervical Cooling

Sponsor
University of Vermont (Other)
Overall Status
Completed
CT.gov ID
NCT02431026
Collaborator
Cryothermic Systems, Inc. (Industry)
6
1
2
15
0.4

Study Details

Study Description

Brief Summary

The American Heart Association (AHA) recommends cooling (inducing mild hypothermia) patients who were resuscitated following cardiac arrest but who remained comatose. Induced mild hypothermia is now the standard of care for post-resuscitation patients in the intensive care unit (ICU) setting. The use of cooling has recently moved to pre-hospital and emergency department (ED) application as more current studies show that early initiation of cooling significantly improves neurologic outcomes and survival rates instead of waiting until the patient arrives in the ICU to initiate cooling. In the pre-hospital setting chilled saline (4°C) and packing the body in ice have been the primary methods to initiate induced mild hypothermia The Excel Cryo Cooling System is a non-invasive cervical collar (C-collar) that provides cooling to the carotid arteries, the main blood supply to the brain, and allows for the rapid initiation of selective cerebral cooling. The investigators are planning to use MRI-thermometry to see how quickly the Excel Cryo Cooling Collar can drop brain temperature when applied by itself.

Healthy volunteers will be used for this study to provide important temperature data on the effectiveness of the Excel Cryo Cooling System. The investigators will be able to use the data from this project to further the current clinical research in induced mild hypothermia after cardiac arrest.

Condition or Disease Intervention/Treatment Phase
  • Device: Cooling pack activated Excel Cryo Cooling Collar
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
6 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Masking:
None (Open Label)
Primary Purpose:
Basic Science
Official Title:
Temperature Evaluation by MRI Thermometry During Cervical Cooling
Study Start Date :
Apr 1, 2015
Actual Primary Completion Date :
Apr 1, 2016
Actual Study Completion Date :
Jul 1, 2016

Arms and Interventions

Arm Intervention/Treatment
Experimental: Cooling present

Cooling pack activated before start of MRI scan for the condition "cooling present".

Device: Cooling pack activated Excel Cryo Cooling Collar
Cooling pack will be activated before insertion into collar. The first cooling pack will be replaced 20 minutes later with a new, activated cooling pack.

No Intervention: No cooling present

Cooling pack will not be activated in the condition "no cooling present".

Outcome Measures

Primary Outcome Measures

  1. Rate of cooling [45 minutes]

    MRI thermometry will be used to evaluate the rate of cooling

  2. Time to drop subject temperature 0.8-3.0°C [45 minutes]

    Temperatures changes will be evaluated using MRI thermometry

  3. Time to induced mild hypothermia threshold (34ºC) [45 minutes]

    Temperatures changes will be evaluated using MRI thermometry

  4. Differences and similarities of inducing mild hypothermia with the Excel Cryo Cooling Collar and normothermia [45 minutes]

    Temperatures changes will be evaluated using MRI thermometry

Secondary Outcome Measures

  1. Relationship between MRI temperature of brain and externally measured temperature [45 minutes]

    Skin surface temperature probe will be used to monitor any external temperature changes

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 60 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • 18 years of age

  • Understands the risks involved, as detailed in the informed consent

  • No MRI risk factors

Exclusion Criteria:
  • < 18 years of age & > 60 years of age

  • Pregnant

  • Any known medical problems that limit activity or decrease blood flow: underactive thyroid (hypothyroidism),poor nutrition, stroke, severe arthritis, Parkinson's disease, dementia, significant mental illness besides clinical depression, spinal cord injuries, recent serious burn, disorders that affect sensation in the extremities (e.g., diabetic neuropathy)dehydration, and any condition that limits activity or restrains the normal flow of blood.

  • Taking any medications (except seasonal allergy medication, over-the-counter NSAIDs, acetaminophen, or contraceptives)

  • Oral medications that inhibit the body's ability to respond to cold: Antidepressants, antipsychotics/neuroleptics, including phenothiazines, beta blockers, clonidine, meperidine, sedative-hypnotics.

  • History of cardiac condition in a family member younger than 40 years

  • Inability to fit in the MRI scanner (BMI > 30 kg/m2)

  • MRI risk factors (e.g., claustrophobia, heart condition, metal implants, etc), as detailed in the MRI safety questionnaire Heart rate, blood pressure, respiratory rate, or temperature outside of acceptable ranges.

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of Vermont Medical Center Burlington Vermont United States 05401

Sponsors and Collaborators

  • University of Vermont
  • Cryothermic Systems, Inc.

Investigators

  • Principal Investigator: Daniel Wolfson, MD, University of Vermont

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Daniel Wolfson, MD, Assistant Professor, University of Vermont
ClinicalTrials.gov Identifier:
NCT02431026
Other Study ID Numbers:
  • TEM-C
First Posted:
Apr 30, 2015
Last Update Posted:
Sep 7, 2016
Last Verified:
Sep 1, 2016
Keywords provided by Daniel Wolfson, MD, Assistant Professor, University of Vermont

Study Results

No Results Posted as of Sep 7, 2016